Lysosomal alterations and decreased electrophysiological activity in CLN3 disease patient-derived cortical neurons. [PDF]
CLN3 disease is a lysosomal storage disorder associated with fatal neurodegeneration that is caused by mutations in CLN3, with most affected individuals carrying at least one allele with a 966 bp deletion.
Chear S +12 more
europepmc +2 more sources
Towards Understanding Behaviour and Emotions of Children with CLN3 Disease (Batten Disease): Patterns, Problems and Support for Child and Family. [PDF]
The juvenile variant of Neuronal Ceroid Lipofuscinosis (CLN3 disease/Batten disease) is a rare progressive brain disease in children and young adults, characterized by vision loss, decline in cognitive and motor capacities and epilepsy.
Honingh AK +4 more
europepmc +2 more sources
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease. [PDF]
CLN3 disease, caused by biallelic mutations in the CLN3 gene, is a rare pediatric neurodegenerative disease that has no cure or disease modifying treatment. The development of effective treatments has been hindered by a lack of etiological knowledge, but
Johnson TB +14 more
europepmc +2 more sources
The Batten disease gene CLN3 is required for the response to oxidative stress [PDF]
Mutations in the CLN3 gene cause juvenile neuronal ceroid lipofuscinosis (JNCL or Batten disease), an early onset neurodegenerative disorder. JNCL is the most common of the NCLs, a group of disorders with infant or childhood onset that are caused by single gene mutations.
Tuxworth, Richard I. +5 more
openaire +3 more sources
Early recognition of CLN3 disease facilitated by visual electrophysiology and multimodal imaging. [PDF]
Sakti DH +9 more
europepmc +1 more source
Treatment of non-epileptic episodes of anxious, fearful behavior in adolescent juvenile neuronal ceroid lipofuscinosis (CLN3 disease). [PDF]
Ostergaard JR.
europepmc +1 more source
Etiology of anxious and fearful behavior in juvenile neuronal ceroid lipofuscinosis (CLN3 disease). [PDF]
Ostergaard JR.
europepmc +1 more source
The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample. [PDF]
Wibbeler E +4 more
europepmc +1 more source
Neurofilament light chain levels correlate with clinical measures in CLN3 disease. [PDF]
Dang Do AN +8 more
europepmc +1 more source
Characterizing upper limb function in the context of activities of daily living in CLN3 disease. [PDF]
Hildenbrand H +12 more
europepmc +1 more source

